1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361.
dc.contributor.author | Oudard, Stephane | |
dc.contributor.author | Powles, Thomas | |
dc.contributor.author | Csoszi, Tibor | |
dc.contributor.author | ÖZGÜROĞLU, Mustafa | |
dc.contributor.author | Matsubara, Nobuaki | |
dc.contributor.author | Geczi, Lajos | |
dc.contributor.author | Cheng, Susanna Y. | |
dc.contributor.author | Fradet, Yves | |
dc.contributor.author | Vulsteke, Christof | |
dc.contributor.author | Morales-Barrera, Rafael | |
dc.contributor.author | Flechon, Aude | |
dc.contributor.author | Gunduz, Seyda | |
dc.contributor.author | Loriot, Yohann | |
dc.contributor.author | Rodriguez-Vida, Alejo | |
dc.contributor.author | Mamtani, Ronac | |
dc.contributor.author | Yu, Evan Y. | |
dc.contributor.author | Nam, Kijoeng | |
dc.contributor.author | Imai, Kentaro | |
dc.contributor.author | Moreno, Blanca Homet | |
dc.contributor.author | Alva, Ajjai Shivaram | |
dc.date.accessioned | 2021-12-10T11:48:54Z | |
dc.date.available | 2021-12-10T11:48:54Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Powles T., Csoszi T., ÖZGÜROĞLU M., Matsubara N., Geczi L., Cheng S. Y. , Fradet Y., Oudard S., Vulsteke C., Morales-Barrera R., et al., "1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361.", JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.6, 2021 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.other | av_9615a3fc-efdb-49b1-94d7-3537cdd78a88 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/172673 | |
dc.identifier.uri | https://doi.org/10.1200/jco.2021.39.6_suppl.450 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.title | 1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361. | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
dc.contributor.department | University Of London , , | |
dc.identifier.volume | 39 | |
dc.identifier.issue | 6 | |
dc.contributor.firstauthorID | 2615923 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Makale [92796]